Rafael Arroyo

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Diego Cadavid, Michelle Mellion, Raymond Hupperts et al. · The Lancet Neurology · 2019 · 185 citations

Life Sciences, Immunology, Neurology +11

Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis

Ludwig Kappos, Matthias Mehling, Rafael Arroyo et al. · Neurology · 2015 · 149 citations

Veterinary Medicine, Immunology, Immunization +16

Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: An ex vivo and in vitro longitudinal study in relapsing−remitting multiple sclerosis

Clara de Andrés, Carol Aristimuño, Virginia de las Heras et al. · Journal of Neuroimmunology · 2006 · 132 citations

Life Sciences, Immunology, Neurology +15

Relapsing-Remitting Multiple Sclerosis and Human Herpesvirus 6 Active Infection

Roberto Álvarez‐Lafuente, Virginia de las Heras, Manuel Bartolomé et al. · Archives of Neurology · 2004 · 111 citations

Life Sciences, Microbiology, Molecular Biology +13

Metabolomic signatures associated with disease severity in multiple sclerosis

Pablo Villoslada, Cristina Alonso, Ion Agirrezabal et al. · Neurology Neuroimmunology & Neuroinflammation · 2017 · 111 citations · Full text

Life Sciences, Biochemistry, Mass Spectrometric Analysis +16